New triple combo pill shows promise for diabetes control
NCT ID NCT06495281
First seen Mar 12, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This study looked at how well and how safely a triple combination of diabetes drugs (zemidapa and metformin) works for people with type 2 diabetes. Over 2,000 patients who were already on other diabetes medicines took part. The main goal was to see if their blood sugar levels improved after 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chonnam National University Hwasun Hospital
Hwasun, Jeollanam-do, 58128, South Korea
Conditions
Explore the condition pages connected to this study.